{
    "nct_id": "NCT04730583",
    "official_title": "Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas",
    "inclusion_criteria": "* Adult males and females ≥18 years of age\n* Have a diagnosis of Neurofibromatosis Type 1\n* Patients must be seeking treatment for cutaneous Neurofibromas\n* Patients must have ≥ 6 paired cutaneous Neurofibromas (3 to be treated and 3 untreated) that are visible and measure between 2-4mm in size.\n* Able and willing to comply with all visit, treatment and evaluation schedules and requirements\n* Able to understand and provide written informed consent\n* Access to a Smart Phone to be able to take and upload photographs to an application\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "* Patients who are undergoing other treatment modalities or investigational agents for their cNF lesions\n* Individuals who cannot give informed consent or adhere to study schedule\n* Actively tanning during the course of the study\n* Adverse reactions to compounds of any external agent (e.g., gels, lotions or anesthetic creams) required for use in the study, if no alternative to the said agent exists;\n* Known allergy to injectable anesthetics or deoxycholic acid\n* Any condition which, in the Investigator's opinion, would make it unsafe (for the participant or study personnel) to treat the participant as part of this research study;\n* Pregnant females, due to possible discomfort with the procedure even though the procedure is localized and there is no new drug.",
    "miscellaneous_criteria": ""
}